MoneyWorks4Me

The sales declined to Rs. 3300.70 millions for the June 2022 quarter as compared to Rs. 4055.70 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2022 is Rs. -191.80 millions as compared to Net Profit of Rs. 505.60 millions of corresponding quarter ended June 2021Operating profit for the quarter ended June 2022 decreased to 161.60 millions as compared to 976.60 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 3300.70 4055.70 -18.62 3300.70 4055.70 -18.62 12683.40 16168.80 -21.56
Other Income 64.80 58.00 11.72 64.80 58.00 11.72 187.60 284.10 -33.97
PBIDT 161.60 976.60 -83.45 161.60 976.60 -83.45 991.10 4137.40 -76.05
Interest 225.00 189.20 18.92 225.00 189.20 18.92 752.70 844.70 -10.89
PBDT -63.40 781.60 -108.11 -63.40 781.60 -108.11 203.50 3292.70 -93.82
Depreciation 280.50 276.00 1.63 280.50 276.00 1.63 1120.10 1083.10 3.42
PBT -343.90 505.60 -168.02 -343.90 505.60 -168.02 -916.60 2209.60 -141.48
TAX -152.10 0.00 0.00 -152.10 0.00 0.00 -331.00 0.00 0.00
Deferred Tax -152.10 -88.40 72.06 -152.10 -88.40 72.06 -331.00 -386.40 -14.34
PAT -191.80 505.60 -137.94 -191.80 505.60 -137.94 -585.60 2209.60 -126.50
Equity 360.00 359.20 0.22 360.00 359.20 0.22 360.00 359.30 0.19
PBIDTM(%) 4.90 24.08 -79.67 4.90 24.08 -79.67 7.81 25.59 -69.46
Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..